Biosimilar News: Stada, Alvotech Launch the First Ustekinumab Biosimilar Across Europe
The Dermatology Digest
JULY 22, 2024
Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.
Let's personalize your content